Fate Therapeutics, Inc.FATENASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-1911.22%
↓ 125% vs avg
Percentile
P7
Near historical low
Streak
2 yr
Consecutive declineContracting
Average
-847.98%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -1911.22% | -47.5% |
| 2024 | -1295.41% | -377.9% |
| 2023 | -271.09% | +11.4% |
| 2022 | -305.95% | +19.1% |
| 2021 | -378.08% | +4.9% |
| 2020 | -397.65% | +54.9% |
| 2019 | -882.06% | +34.4% |
| 2018 | -1343.84% | -35.5% |
| 2017 | -991.55% | -41.1% |
| 2016 | -702.95% | - |